PEOPLE - Percardia (US) makes appointment:
This article was originally published in Clinica
Early stage medical device company Percardia (Merrimack, New Hampshire) has named Richard Popp as a member of the board. Percardia develops products aimed at treating coronary artery disease. Dr Popp is currently Professor of Medicine at Stanford University.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.